Neuroinflammation as a common feature of neurodegenerative disorders
L Guzman-Martinez, RB Maccioni, V Andrade… - Frontiers in …, 2019 - frontiersin.org
Neurodegenerative diseases share the fact that they derive from altered proteins that
undergo an unfolding process followed by formation of β-structures and a pathological …
undergo an unfolding process followed by formation of β-structures and a pathological …
α-synuclein in the pathophysiology of Alzheimer's disease
D Twohig, HM Nielsen - Molecular neurodegeneration, 2019 - Springer
The Alzheimer's disease (AD) afflicted brain is neuropathologically defined by extracellular
amyloid-β (Aβ) plaques and intraneuronal neurofibrillary tangles composed of …
amyloid-β (Aβ) plaques and intraneuronal neurofibrillary tangles composed of …
Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
KA Jellinger, AD Korczyn - BMC medicine, 2018 - Springer
Abstract Background Dementia with Lewy bodies (DLB) and Parkinson's disease dementia
(PDD), which share many clinical, neurochemical, and morphological features, have been …
(PDD), which share many clinical, neurochemical, and morphological features, have been …
Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies
KA Jellinger - Journal of neural transmission, 2018 - Springer
Dementia with Lewy bodies (DLB) and Parkinson's disease-dementia (PDD), although
sharing many clinical, neurochemical and morphological features, according to DSM-5, are …
sharing many clinical, neurochemical and morphological features, according to DSM-5, are …
Biophysical processes underlying cross-seeding in amyloid aggregation and implications in amyloid pathology
MI Ivanova, Y Lin, YH Lee, J Zheng… - Biophysical chemistry, 2021 - Elsevier
Abnormal aggregation of proteins into filamentous aggregates commonly associates with
many diseases, such as Alzheimer's disease, Parkinson's disease and type-2 diabetes …
many diseases, such as Alzheimer's disease, Parkinson's disease and type-2 diabetes …
Mild behavioral impairment as a marker of cognitive decline in cognitively normal older adults
Objective Mild behavioral impairment (MBI) is a neurobehavioral syndrome characterized by
later life emergent neuropsychiatric symptoms (NPS) that represent an at-risk state for …
later life emergent neuropsychiatric symptoms (NPS) that represent an at-risk state for …
Structure, function and toxicity of alpha‐synuclein: the Bermuda triangle in synucleinopathies
A Villar‐Piqué, T Lopes da Fonseca… - Journal of …, 2016 - Wiley Online Library
Parkinson's disease belongs to a group of currently incurable neurodegenerative disorders
characterized by the misfolding and accumulation of alpha‐synuclein aggregates that are …
characterized by the misfolding and accumulation of alpha‐synuclein aggregates that are …
Altered proteins in the aging brain
A Elobeid, S Libard, M Leino… - … of Neuropathology & …, 2016 - academic.oup.com
We assessed the prevalence of common altered brain proteins in 296 cognitively
unimpaired subjects ranging from age 50 to 102 years. The incidence and the stage of …
unimpaired subjects ranging from age 50 to 102 years. The incidence and the stage of …
Vitamin supplementation and dementia: a systematic review
V Gil Martínez, A Avedillo Salas, S Santander Ballestín - Nutrients, 2022 - mdpi.com
Background: Dementia is a syndrome characterized by progressive cognitive impairment
that interferes with independent function in daily activities. Symptoms of dementia depend …
that interferes with independent function in daily activities. Symptoms of dementia depend …
Lewy body disease or diseases with Lewy bodies?
K Menšíková, R Matěj, C Colosimo, R Rosales… - npj Parkinson's …, 2022 - nature.com
The current nosological concept of α-synucleinopathies characterized by the presence of
Lewy bodies (LBs) includes Parkinson's disease (PD), Parkinson's disease dementia (PDD) …
Lewy bodies (LBs) includes Parkinson's disease (PD), Parkinson's disease dementia (PDD) …